Luteinizing hormone‐releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma: A prospective double blind randomized trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.